Surrogate end-point biomarkers in chemopreventive drug development.

IARC scientific publications

Volumn 154, Issue , 2001, Pages 13-26

  Kelloff, G J ^a   Sigman, C C ^a   Hawk, E T ^a   Johnson, K M ^a   Crowell, J A ^a   Guyton, K Z ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

BIOLOGICAL MODEL; DRUG SCREENING; GENETICS; HUMAN; METHODOLOGY; NEOPLASM; PATIENT SELECTION; PRECANCER; REVIEW;

ANTICARCINOGENIC AGENTS; ANTINEOPLASTIC AGENTS; DRUG EVALUATION; HUMANS; MODELS, GENETIC; NEOPLASMS; PATIENT SELECTION; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035228025     PISSN: 03005038     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)